Jun 02, 2020
Evofem Announces Proposed Public Offering of Common Stock
May 21, 2020
PDL BioPharma Completes Distribution of Evofem Biosciences Common Stock to PDL Stockholders
May 18, 2020
PDL BioPharma Declares Distribution Ratio for Dividend of Evofem Biosciences Common Stock to PDL Stockholders
May 13, 2020
Evofem Biosciences to Participate in Virtual Fireside Chat at RBC Capital Markets Global Healthcare Conference
May 05, 2020
PDL BioPharma Declares Dividend of Evofem Biosciences Common Stock to PDL Stockholders
Apr 28, 2020
Evofem Biosciences to Report First Quarter 2020 Results and Provide Corporate Update on Wednesday, May 6, 2020
Apr 27, 2020
Evofem Biosciences Secures up to $25 Million in Convertible Note Financing
Mar 27, 2020
Evofem Biosciences to Present at Solebury Trout Virtual Investor Conference
Mar 25, 2020
Evofem Biosciences Adopts Shareholder Rights Agreement
Mar 03, 2020
Evofem Biosciences to Report Fourth Quarter and Year-end 2019 Results and Provide Corporate Update on March 12, 2020
Dec 18, 2019
U.S. FDA Acknowledges Receipt of Evofem Biosciences' New Drug Application Resubmission for Amphora® for the Prevention of Pregnancy
Dec 03, 2019
PDL BioPharma Congratulates Evofem Biosciences on Achieving Major Regulatory and Clinical Milestones with its Lead Product Candidate Amphora®
Nov 26, 2019
Evofem Biosciences Resubmits New Drug Application to U.S. FDA for Amphora® for the Prevention of Pregnancy
Nov 14, 2019
Evofem Biosciences' CEO Saundra Pelletier Awarded 2019 Business Woman Of The Year
Nov 13, 2019
Evofem Biosciences to Participate in Upcoming Investor Conferences
Sep 25, 2019
Evofem Biosciences to Present at Cantor Global Healthcare Conference on October 4, 2019
Aug 26, 2019
Evofem Biosciences Completes Phase 2b 'AMPREVENCE' Trial of Amphora for Prevention of Chlamydia and Gonorrhea in Women
Aug 22, 2019
Evofem Biosciences to Present at Upcoming Healthcare Conferences
Jul 30, 2019
Evofem Biosciences to Report Second Quarter 2019 Results and Provide Corporate Update on August 6, 2019
Jul 01, 2019
Evofem Biosciences Added to Russell 3000® Index